Martin Faehling - Dissemin

Language
Login

All papers authored by Martin Faehling

This paper was not found in any repository, but could be made available legally by the author.

2024 Miriam Blasi, Jonas Kuon, Heike Lüders, Daniel Misch, Diego Kauffmann-Guerrero, Moritz Hilbrandt, Daniel Kazdal

ORCID

, Roger-Fei Falkenstern-Ge, Björn Hackanson

ORCID

, Sebastian Dintner, Martin Faehling

ORCID

, Martina Kirchner

ORCID

, Anna-Lena Volckmar

ORCID

, Hans-Georg Kopp

ORCID

, Michael Allgäuer

ORCID

and 7 other authors

First-line immunotherapy for lung cancer with MET exon 14 skipping and the relevance of TP53 mutations

Upload

This paper was not found in any repository, but could be made available legally by the author.

2022 Petros Christopoulos

ORCID

, Klaus Kluck, Martina Kirchner

ORCID

, Heike Lüders, Julia Roeper, Roger-Fei Falkenstern-Ge, Marlen Szewczyk, Florian Sticht, Felix C. Saalfeld

ORCID

, Claas Wesseler, Björn Hackanson, Sebastian Dintner, Martin Faehling

ORCID

, Jonas Kuon, Melanie Janning and 22 other authors

The impact of TP53 co-mutations and immunologic microenvironment on outcome of lung cancer with EGFR exon 20 insertions

Upload

This paper is made freely available by the publisher.

Martin Faehling

ORCID

, Hanno Witte, Martin Sebastian, Matthias Ulmer, Rainer Sätzler, Konrad Steinestel, Wolfgang M. Brückl

ORCID

, Georg Evers, Christian Meyer zum Büschenfelde, Annalen Bleckmann

Real-world multicentre analysis of neoadjuvant immunotherapy and chemotherapy in localized or oligometastatic non-small cell lung cancer (KOMPASSneoOP)

Download from journals.sagepub.com

This paper was not found in any repository, but could be made available legally by the author.

2021 Martin Faehling

ORCID

, Sabine Fallscheer, Sebastian Kramberg, Jörn Sträter, Susanne Eschmann, Rainer Sätzler, Frank Heinzelmann

Prospective trial of immuno(chemo)therapy before resection, definitive chemoradiotherapy or palliative therapy in patients with locally advanced or oligometastatic non-small cell lung cancer without a primary curative option

Upload

This paper is made freely available by the publisher.

2020 Harald Kaemmerer, Matthias Gorenflo, Dörte Huscher

ORCID

, David Pittrow, Christian Apitz, Helmut Baumgartner, Felix Berger, Leonhard Bruch, Eva Brunnemer, Werner Budts

ORCID

, Martin Claussen, Gerry Coghlan, Ingo Dähnert

ORCID

, Michele D’Alto

ORCID

, Marion Delcroix

ORCID

and 56 other authors

Pulmonary Hypertension in Adults with Congenital Heart Disease: Real-World Data from the International COMPERA-CHD Registry

Download from doi.org

This paper is made freely available by the publisher.

2018 Martin Faehling

ORCID

, Birgit Schwenk, Sebastian Kramberg, Sabine Fallscheer, Matthias Leschke, Jörn Sträter, Robert Eckert

Second malignancy in non-small cell lung cancer (NSCLC): prevalence and overall survival (OS) in routine clinical practice

Download from link.springer.com

This paper was not found in any repository, but could be made available legally by the author.

2016 M. Faehling

ORCID

, J. Achenbach, P. Staib, U. Steffen, H. W. Tessen, V. E. Gaillard, W. Brugger

Erlotinib in routine clinical practice for first-line maintenance therapy in patients with advanced non-small cell lung cancer (NSCLC)

Upload

Missing publications? Search for publications with a matching author name.